People who have been exposed to a seasonal “common cold” may experience less severe COVID-19 symptoms. While we’ve discussed this topic previously, a study from the Journal of Clinical Investigation reports the first clinical evidence of cross reactivity with the common cold and COVID. This is due to previous immune responses against the four endemic…
As with most things biology, there is a relatively tight range for optimal: insufficiency of compound X is a problem and excess of compound X is a problem as well, for a different, but related, set of mechanisms…. I have been particularly interested in this concept for the duration of my career, seeing this U…
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines and chemokines, including interleukin-1 (IL-1), IL-6, CCL2 protein, and CXCL10 protein. In…
In this paper, the Institute for Functional Medicine (IFM) added to the list of nutraceuticals and botanicals introduced earlier in their first article, The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents. Periodically, IFM will update the original list to highlight other agents that may be considered as complementary treatments against COVID-19. Along…
